[go: up one dir, main page]

UA27048C2 - Medicinal preparation of immunoreplacement activity the basis of cellular suspension and method for treatment of diabetes mellitus by the use of this preparation - Google Patents

Medicinal preparation of immunoreplacement activity the basis of cellular suspension and method for treatment of diabetes mellitus by the use of this preparation

Info

Publication number
UA27048C2
UA27048C2 UA94020324A UA94020324A UA27048C2 UA 27048 C2 UA27048 C2 UA 27048C2 UA 94020324 A UA94020324 A UA 94020324A UA 94020324 A UA94020324 A UA 94020324A UA 27048 C2 UA27048 C2 UA 27048C2
Authority
UA
Ukraine
Prior art keywords
preparation
immunoreplacement
activity
basis
treatment
Prior art date
Application number
UA94020324A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Олександр Іванович Смикодуб
Александр Иванович Смыкодуб
Андрій Семенович Єфімов
Андрей Семенович Ефимов
Алла Володимирівна Новицька
Алла Владимировна Новицкая
Original Assignee
Центр Ембріональних Тканин "Емселл"
Центр эмбриональных тканей "ЭМСЕЛЛ"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Центр Ембріональних Тканин "Емселл", Центр эмбриональных тканей "ЭМСЕЛЛ" filed Critical Центр Ембріональних Тканин "Емселл"
Priority to UA94020324A priority Critical patent/UA27048C2/en
Priority to RU95120155/14A priority patent/RU2126260C1/en
Priority to CA002152078A priority patent/CA2152078A1/en
Priority to NL9420012A priority patent/NL194693C/en
Priority to PCT/UA1994/000025 priority patent/WO1995011659A2/en
Publication of UA27048C2 publication Critical patent/UA27048C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The medicinal preparation of immunoreplacement activity on the basis of cellular suspension is prepared of the native or cryobanked hemopoietic cells of embryonic liver and/or spleen. The number of nucleacontaining cells in such suspension is from 5 to 900106/ml. The number of colony-forming units of granulomonocytic row is from 20 to 80/103/ml. The number of colony-forming units of blasts is from 0,5 to 9/103/ml. The number of early hemopoiesis precursors is from 1 to 9/106/ml.
UA94020324A 1993-10-18 1993-10-18 Medicinal preparation of immunoreplacement activity the basis of cellular suspension and method for treatment of diabetes mellitus by the use of this preparation UA27048C2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
UA94020324A UA27048C2 (en) 1993-10-18 1993-10-18 Medicinal preparation of immunoreplacement activity the basis of cellular suspension and method for treatment of diabetes mellitus by the use of this preparation
RU95120155/14A RU2126260C1 (en) 1993-10-18 1994-10-17 Cell suspension-based immunocorrecting drug and using this drug in a method of treating diabetes mellitus
CA002152078A CA2152078A1 (en) 1993-10-18 1994-10-17 Pharmaceutical preparation with immuno-correcting properties based on a cell suspension, and a method of treating sugar diabetes using said preparation
NL9420012A NL194693C (en) 1993-10-18 1994-10-17 Method for the preparation of medicinal preparations for treating diabetes.
PCT/UA1994/000025 WO1995011659A2 (en) 1993-10-18 1994-10-17 Pharmaceutical preparation with immuno-correcting properties based on a cell suspension, and a method of treating sugar diabetes using said preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA94020324A UA27048C2 (en) 1993-10-18 1993-10-18 Medicinal preparation of immunoreplacement activity the basis of cellular suspension and method for treatment of diabetes mellitus by the use of this preparation

Publications (1)

Publication Number Publication Date
UA27048C2 true UA27048C2 (en) 2000-02-28

Family

ID=21688946

Family Applications (1)

Application Number Title Priority Date Filing Date
UA94020324A UA27048C2 (en) 1993-10-18 1993-10-18 Medicinal preparation of immunoreplacement activity the basis of cellular suspension and method for treatment of diabetes mellitus by the use of this preparation

Country Status (5)

Country Link
CA (1) CA2152078A1 (en)
NL (1) NL194693C (en)
RU (1) RU2126260C1 (en)
UA (1) UA27048C2 (en)
WO (1) WO1995011659A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000035464A1 (en) * 1998-12-16 2000-06-22 Tsentr Embrionalnykh Tkanei 'emcell' Method for treating patients using cellular suspensions of embryonic tissues
RU2160112C1 (en) * 2000-04-10 2000-12-10 Сухих Геннадий Тихонович Method for producing cellular transplant from fetus tissues
RU2007112288A (en) * 2007-04-03 2008-10-10 Александр Сергеевич Ботин (RU) COMPOSITION FOR STIMULATING GROWTH AND REGENERATION OF CELLS, AND ALSO WAY OF ITS PRODUCTION

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1592637A (en) * 1978-03-22 1981-07-08 Parmer L P Lipid extract for inhibiting platelet function in blood
US4254103A (en) * 1979-06-08 1981-03-03 Institul de Cercetari Chimicofarmaceutice Hepatoprotector Factor (HF) and method of treatment
HU182087B (en) * 1980-01-15 1983-12-28 Mta Kiserleti Orvostudomanyi K Process for preparing an active substance for the selective inhibition of the multiplication of normal cells and of cells in myeloide leukemia
SU1158201A1 (en) * 1983-06-03 1985-05-30 Ленинградское Ордена Ленина,Ордена Трудового Красного Знамени Производственное Объединение Мясной Промышленности Им.С.М.Кирова Method of obtaining stimulator from mammalia spleen
US5055296A (en) * 1988-08-04 1991-10-08 Wagle Sudhakar S Method of treating chronic fatigue syndrome
IT1244879B (en) * 1990-12-11 1994-09-12 Alberto Bartorelli EXTRACTS FROM ANIMAL TISSUES, USEFUL IN THERAPY AND DIAGNOSTICS.

Also Published As

Publication number Publication date
CA2152078A1 (en) 1995-05-27
NL194693C (en) 2002-12-03
WO1995011659A3 (en) 1995-06-01
NL9420012A (en) 1995-12-01
NL194693B (en) 2002-08-01
WO1995011659A2 (en) 1995-05-04
RU2126260C1 (en) 1999-02-20

Similar Documents

Publication Publication Date Title
CA2126091A1 (en) Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides
CA2189250A1 (en) Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
CA2153584A1 (en) Cytokine restraining agents
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
IL93360A (en) Bactericidal/permeability increasing protein or biologically active analogs thereof and pharmaceutical compositions containing them
ES2010226A6 (en) Stable granulocyte colony stimulating factor composition
CS141387A2 (en) Microbicide
BG91270A (en) ANTIVIRAL AND ANTIBACTERIAL AGENT AND METHOD OF ITS USE
IE862543L (en) Pharmaceutical compositions
MX9603479A (en) 4-amino derivatives of mycophenolic acid with immunosuppressant activity.
CA2223433A1 (en) Ob protein compositions and methods
HU913776D0 (en) Process for the production of heparosane-n,o-sulphates, and medical preparations containing them as active agents
EG18379A (en) Novel pharmacological compounds
EP1535929A3 (en) Megakaryocyte stimulating factors
IL99146A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
NZ225976A (en) Method of preserving hay quality by addition of bacillus pumilus and compositions thereof
EP0340333A3 (en) Novel physiologically active polypeptide and pharmaceutical composition
HK1001004A1 (en) Bpc peptides their preparation and use
EP0286441A3 (en) Novel cytotoxic protein
KR880011198A (en) Cyclic Peptides and Methods for Making the Same
ZA934037B (en) Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same.
MD1360C2 (en) A fungicidal composition, process for control and revention of plants Oomycetes infection
HUT58765A (en) Process for producing peptide compounds and pharmaceutical compositions containing them as active components
HUT46837A (en) Compositions of insectifuge and acarifuge activity containing alpha, omega-amino-alkohol derivatives as active components and process for producing the active components
ES466037A1 (en) 4-Deoxy-4-substituted amino derivatives of oleandomycin